Alnylam to Webcast Presentations at Upcoming March Investor Conferences
Monday, February 22nd 2021 at 9:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– class= »bwalignl »> Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics…
Monday, February 22nd 2021 at 9:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– class= »bwalignl »> Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics…
Thursday, February 25th 2021 at 5:40pm UTC DUBLIN–(BUSINESS WIRE)– The « CRISPR & Cas Genes Market Size, Share & Trends Analysis…
Wednesday, February 24th 2021 at 1:00pm UTC – Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D. join as…
Friday, February 26th 2021 at 7:00am UTC Asset transfer furthers Takeda’s global strategy to focus on five key business areas…
Thursday, February 25th 2021 at 12:00pm UTC — Achieved Favorable Clinical Results Across Four First-in-Class Gene Therapy Programs for Danon…
Monday, February 22nd 2021 at 10:00am UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling…
Thursday, February 11th 2021 at 10:03pm UTC Total of 300 million doses ordered by the U.S government to date Additional…
Wednesday, February 17th 2021 at 1:00pm UTC BOULDER, Colo.–(BUSINESS WIRE)– Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth quarter…
Wednesday, February 10th 2021 at 12:44pm UTC SOMERSET, N.J.–(BUSINESS WIRE)– Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of…
Monday, February 15th 2021 at 3:06pm UTC DUBLIN–(BUSINESS WIRE)– The « Single Cell Genomics Markets » report has been added to ResearchAndMarkets.com’s…